MEDTRONIC PLC |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.7 USD | -0.24% |
|
+0.87% | -0.95% |
| Apr. 26 | Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain | MT |
| Apr. 26 | Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator | DJ |
Presenter SpeechRyan Weispfenning (Executives)Good morning. Welcome to a crisp fall morning he...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows:
- general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.;
- cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.;
- vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.;
- spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity;
- neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%);
- diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps;
- neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc.
Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
2024-05-23
- Q4 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
81.9
USD
Average target price
94.77
USD
Spread / Average Target
+15.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -0.95% | 109B | |
| -4.71% | 185B | |
| -3.81% | 68.54B | |
| +4.50% | 51.74B | |
| +9.67% | 45.22B | |
| +3.12% | 41.74B | |
| +4.73% | 26.83B | |
| +3.64% | 26.69B | |
| +11.62% | 25.63B | |
| -0.90% | 24.98B |
- Stock Market
- Equities
- MDT Stock
- News Medtronic plc
- Transcript : Medtronic plc, Q2 2024 Earnings Call, Nov 21, 2023